Axplora Adds Stephan Haitz as President of Novasep CDMO Business Unit
Executive comes with over 20 years of experience in the industry.
Axplora, a partner to pharma and biotech companies for complex APIs, announced the appointment of Stephan Haitz, PhD, as its new president of the Novasep contract development and manufacturing organization (CDMO) business unit, effective Nov. 1, taking over from Jean Bléhaut. Haitz comes with over 20 years of experience in the pharmaceutical industry, holding multiple management positions within CDMOs such as Solvias and Lonza.
“I’d like to warmly thank Jean for many years of service at Novasep and wish him the best for the future. I’m now looking forward to entrusting the reins of the BU to Stephan to further consolidate the company’s position as a leader in the CDMO market, while bringing new energy and ideas,” stated Sylke Hassel, PhD, CEO, Axplora. Stephan will work closely with the Executive Committee and particularly with Dr. Pere Paton, our Chief Operations Officer.”
Reference: Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit. Axplora. October 18, 2023. Accessed October 23, 2023. https://www.axplora.com/axplora-appoints-dr-stephan-haitz-as-president-of-its-novasep-cdmo-business-unit/
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
